XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Other Long-Term Liabilities
 9 Months Ended
Sep. 30, 2022
Other Liabilities Disclosure [Abstract]  
OTHER LONG-TERM LIABILITIES OTHER LONG-TERM LIABILITIES
(in millions)September 30,
2022		December 31,
2021
Contingent consideration$4.5 $5.4 
Other0.1 0.2 
Total other long-term liabilities$4.6 $5.6 
The Company's balance of other long-term liabilities at September 30, 2022 and December 31, 2021 consisted primarily of the long-term portion of contingent consideration related to the acquisition of Sividon Diagnostics.